Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication
Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The project, funded by the Bill & Melinda Gates Foundation, has the potential to bolster efforts to sustain a polio-free world after the disease has been eradicated.
With a 99% reduction in polio cases worldwide since 1988, the global eradication of polio is now in sight. In support of the polio eradication initiative, novel oral polio vaccine (nOPV) candidates are being developed that are intended to reduce the risk from rare cases of vaccine-associated disease. The novel strains are intended to be stockpiled as protection against possible future outbreaks after polio has been eradicated.
The novel candidate vaccine strains currently in manufacturing at Batavia Biosciences have been developed by the National Institute for Biological Standards and Control (NIBSC) in the United Kingdom, the U.S. Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), and the University of California at San Francisco (UCSF). Batavia Biosciences contributes its extensive polio vaccine development experience and works closely with one of the world’s leading OPV vaccine manufacturers, BioFarma, in Indonesia, under the nOPV consortium managed by PATH.
Chris Yallop, CSO of Batavia Biosciences, states: “With such a consortium, I am convinced that we will succeed in taking the next step in the development of this much needed vaccine.”
Menzo Havenga, CEO of Batavia Biosciences, states: “We are proud to work with the Bill & Melinda Gates FoundationPATH, NIBSC and BioFarma, and on the goal of bringing a safer oral polio vaccine to help keep the world polio-free.”
Researchers Discover Key Link Between Mitochondria and Cocaine AddictionNews
Researchers were able to block response in mitochondria to cocaine.
A Greener Way to Make KetonesNews
Researchers at McGill University have discovered a new, more environmentally friendly way to make ketones, an important chemical ingredient in pharmaceuticals. While ketones are found in a wide range of useful chemicals, they are commonly prepared through energy-intensive, multi-step technologies that create significant chemical waste.READ MORE
Natoli Engineering Donates Equipment to Strengthen Purdue University’s Continuous Manufacturing ResearchNews
Natoli Engineering Company, Inc., the global leader in tablet compression tooling, continues to drive innovation in the tableting industry by donating a new NP-400 tablet press and related components to Purdue University in West Lafayette, IndianaREAD MORE
Comments | 0 ADD COMMENT
4th International Conference on Crystallography & Novel Materials
Nov 19 - Nov 20, 2018